Emerging Discussions on Folinic Acid and Acetaminophen in Autism - PubMed

6 hours ago

Folinic acid shows short-term improvements in verbal or social communication in autism, especially in subgroups like children with folate receptor autoantibodies (FRAA).
Evidence for folinic acid remains limited due to small sample sizes, single-centre designs, and variable outcome measures.
A 2024 randomised trial on folinic acid was retracted in 2026, highlighting the need for caution with early findings.
A major Swedish cohort study found no association between prenatal acetaminophen use and autism, ADHD, or intellectual disability after adjusting for familial factors.
Clear, evidence-based communication is essential to help families navigate emerging evidence without being misled by premature claims.

Hasty Briefsbeta